NASDAQ:YIN - Yintech Investment Stock Price, Forecast & News

Yintech Investment trades on the NASDAQ under the ticker symbol "YIN."

Yintech Investment Holdings Ltd - (NASDAQ:YIN) released its quarterly earnings data on Monday, December, 2nd. The financial services provider reported $0.20 EPS for the quarter. The financial services provider had revenue of $71.46 million for the quarter. View Yintech Investment's Earnings History.

Yintech Investment is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Yintech Investment.

Yintech Investment updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, December, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $54.563-55.962 million.

News stories about YIN stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Yintech Investment earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Yintech Investment.

Some companies that are related to Yintech Investment include INTL Fcstone (INTL), OTC Markets Group (OTCM), National (NHLD), Global Brokerage (GLBR) and Primus Guaranty (PRSG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Yintech Investment investors own include Allena Pharmaceuticals (ALNA), Pieris Pharmaceuticals (PIRS), Sinovac Biotech (SVA), Transcat (TRNS), KeyCorp (KEY), AcelRx Pharmaceuticals (ACRX), Gilead Sciences (GILD), Leap Therapeutics (LPTX), Park City Group (PCYG) and REDHILL BIOPHAR/S (RDHL).

(YIN) raised $101 million in an initial public offering (IPO) on Wednesday, April 27th 2016. The company issued 7,500,000 shares at a price of $12.50-$14.50 per share. Jefferies served as the underwriter for the IPO and Ping An of China Securities (Hong Kong) was co-manager.

Yintech Investment's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.11%) and Alliancebernstein L.P. (0.03%).

YIN stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P. and Renaissance Technologies LLC.

Shares of YIN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of YIN stock can currently be purchased for approximately $5.66.

Yintech Investment has a market capitalization of $404.29 million and generates $157.04 million in revenue each year. Yintech Investment employs 2,921 workers across the globe.View Additional Information About Yintech Investment.

The official website for Yintech Investment is http://www.yintech.net/.

Yintech Investment's mailing address is LUJIAZUI INVESTMENT TOWER NO.360 PUDIAN ROAD 3RD FLOOR, SHANGHAI F4, 200125. The financial services provider can be reached via phone at 86-21-2028-9009 or via email at [email protected]